MARKET

EGRX

EGRX

Eagle Pharmaceut
NASDAQ
4.280
-0.150
-3.39%
Closed 16:00 09/18 EDT
OPEN
4.420
PREV CLOSE
4.430
HIGH
4.570
LOW
4.150
VOLUME
49.26K
TURNOVER
--
52 WEEK HIGH
16.21
52 WEEK LOW
3.210
MARKET CAP
55.58M
P/E (TTM)
4.698
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EGRX last week (0909-0913)?
Weekly Report · 2d ago
Weekly Report: what happened at EGRX last week (0902-0906)?
Weekly Report · 09/09 10:19
Weekly Report: what happened at EGRX last week (0826-0830)?
Weekly Report · 09/02 10:21
Eagle Pharmaceuticals Struggles with Financial Compliance and Nasdaq Listing
TipRanks · 08/27 20:58
Eagle Pharmaceuticals receives delisting notification from Nasdaq
Seeking Alpha · 08/27 20:49
Eagle Pharmaceuticals Receives Delisting Notification From Nasdaq's Listing Qualifications Department
Benzinga · 08/27 20:34
EAGLE PHARMACEUTICALS ANNOUNCES RECEIPT OF DELISTING NOTIFICATION FROM NASDAQ
Reuters · 08/27 20:30
Weekly Report: what happened at EGRX last week (0819-0823)?
Weekly Report · 08/26 10:19
More
About EGRX
Eagle Pharmaceuticals, Inc. is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial capabilities. The Company is focused on developing medicines that result in improvements in patients' lives. The Company's commercialized products include vasopressin, PEMFEXY, RYANODEX, BENDEKA, BELRAPZO, TREAKISYM (Japan), and BYFAVO and BARHEMSYS through its wholly owned subsidiary Acacia Pharma Inc. Its oncology and central nervous system (CNS)/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. The Company also has a research and development facility in Cambridge, Massachusetts. The Company has office space in Palm Beach Gardens, Florida and Indianapolis, Indiana. The Company’s subsidiaries include Eagle Biologics, Inc., Eagle Research Lab Limited, Acacia Pharma Group plc, Acacia Pharma Limited and Acacia Pharma Inc.

Webull offers Eagle Pharmaceuticals Inc stock information, including NASDAQ: EGRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EGRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EGRX stock methods without spending real money on the virtual paper trading platform.